Bridgefront Capital, LLC

SEC CIK: 0001725690
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

EBS holding history

Emergent BioSolutions Inc. in every 13F filed by Bridgefront Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EBS overview All 13F holders of EBS Full Q2 2026 holdings

Shares (Q2 2023): 0; Sold out in Q2 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2021

Holdings of EBS by Bridgefront Capital, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2023	0	$0	0.0%	−25,880−100.0%	Sold out	Holders
Q1 2023	25,880	$268.1K	0.2%	+25,880	New	Holders
Q2 2021	0	$0	0.0%	−7,765−100.0%	Sold out	Holders
Q1 2021	7,765	$721.0K	0.2%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.